window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biomanufacturing

  • Biomanufacturing,CDMOs & Manufacturing,Drug Development,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow

    Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

    April 17, 2026
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    Scaling production of adeno-associated virus vectors remains a key barrier [...]

    April 9, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Infectious Diseases,Partnerships & Funding,Vaccines

    Evotec unit secures BARDA deal to optimise Ebola antibody manufacturing

    Just – Evotec Biologics has been selected by BARDA to [...]

    March 23, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Events and Conferences,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    Fujifilm Biotechnologies unveils ShunzymeX purification technology for biologics

    FUJIFILM Biotechnologies has unveiled ShunzymeX, a purification technology designed to [...]

    March 6, 2026
  • Biologics & Biosimilars,Biomanufacturing,Biotech,Clinical Development,Clinical Trials,Drug approval,Drug Development,FDA,Rare Diseases,Research & Development

    Hansa Biopharma’s BLA for imlifidase accepted by FDA

    Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]

    February 19, 2026
  • Antibody drug conjugates,Biologics & Biosimilars,Biomanufacturing,CDMOs & Manufacturing,Drug Development,Research & Development,Technology and platforms

    Lonza expands bioconjugate capabilities at Oss site to support ADC development

    Lonza expands its Advanced Synthesis capabilities at Oss, integrating ADC [...]

    February 19, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Delivery & Formulation,European biotech,Facilities and infrastructure,Healthcare leadership,Manufacturing,Movers & Shakers,Pharmaceuticals and therapeutics

    Axplora expands lyophilisation capacity at Le Mans

    Axplora is investing several million euros to expand lyophilisation capacity [...]

    February 19, 2026
  • Biomanufacturing,Cardiovascular diseases,Cell & Gene Therapy,Clinical Development

    CellProthera acquires full rights to transendocardial catheter from Celyad Oncology

    CellProthera has acquired full rights to the transendocardial catheter originally [...]

    February 15, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Facilities and infrastructure,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics,Sustainability

    Fujifilm invests £400M in UK biomanufacturing expansion with new Teesside single-use facility

    FUJIFILM Biotechnologies has opened a £400M biomanufacturing and process development [...]

    February 13, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Movers & Shakers,Regulatory Affairs,Technology and platforms

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    January 30, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
  • European liver experts highlight rising MASLD burden at EASL symposium in Budapest
    Categories: Clinical studies, Gastroenterology, Healthcare leadership, Liver disease, Metabolic Diseases
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top